Adjuvant chemotherapy for primary breast cancer. Review uri icon

Overview

abstract

  • For patients with hormone-unresponsive or higher-risk operable early-stage breast cancer, adjuvant chemotherapy significantly reduces the risks of relapse and death. The prognosis for such patients, especially those presenting with extensive axillary lymph node involvement, remains poor. New chemotherapy agents and novel administration schedules have recently been shown to improve clinical outcome. This overview provides a summary of the state of the art and the most recent developments regarding adjuvant chemotherapy for primary breast carcinoma.

publication date

  • January 1, 2005

Research

keywords

  • Breast Neoplasms

Identity

Scopus Document Identifier

  • 14044250220

Digital Object Identifier (DOI)

  • 10.1007/s11912-005-0021-1

PubMed ID

  • 15610682

Additional Document Info

volume

  • 7

issue

  • 1